Merrill Goozner. Show Affiliations »
Abstract
Mesh： See more » Advisory CommitteesAndrogen Antagonists/therapeutic useCancer Vaccines/therapeutic useConfounding Factors, EpidemiologicDisease-Free SurvivalDrug ApprovalEvidence-Based MedicineHumansMaleMedicaidMedicareProstate-Specific Antigen/bloodProstatic Neoplasms/drug therapyProstatic Neoplasms/immunologyProstatic Neoplasms/mortalityProstatic Neoplasms/prevention & controlRandomized Controlled Trials as TopicSurvival AnalysisTissue Extracts/therapeutic useUnited States/epidemiologyUnited States Food and Drug Administration
Substances： See more » Androgen AntagonistsCancer VaccinesTissue Extractssipuleucel-TProstate-Specific Antigen
Year: 2011 PMID： 21303996 DOI： 10.1093/jnci/djr041
Source DB: PubMed Journal: J Natl Cancer Inst ISSN： 0027-8874 Impact factor: 13.506